Consistent availability of medicines is one of the most fundamental requirements of a functioning healthcare system. In South Africa, ensuring continuous access to essential medicines remains a complex challenge, shaped by the interplay of procurement processes, supply chain infrastructure, logistics systems, and broader healthcare demands. These disruptions, often systemic in nature, reflect a combination of procurement inefficiencies, infrastructure gaps, supplier payment delays, and fragmented logistics. As the country works toward improving healthcare delivery, a deeper understanding of the supply chain ecosystem and its pressure points is key to supporting resilience and equitable medicine access.
Stockouts in public health facilities are a known concern, particularly affecting essential medicines used to treat both acute and chronic conditions. A 2021 report by the Stop Stockouts Project found that more than 30% of public health facilities surveyed reported stock shortages within a three-month period. These ranged from basic antibiotics to chronic disease medications such as insulin and antihypertensives. While some of these shortages can be attributed to global supply constraints or disruptions in the manufacturing of active pharmaceutical ingredients, many are the result of localised administrative and logistical factors.
One major contributing factor is procurement inefficiency. The public sector supply chain is centrally coordinated, involving both the National Department of Health and provincial distribution depots. Timely procurement is critical to this system, and when tender processes or supplier onboarding are delayed, it can impact the continuity of stock. Demand forecasting and data accuracy are also central to balancing supply. Variability in consumption reporting across facilities can lead to stock imbalance, overstocking in some areas and shortages in others, highlighting the need for improved planning systems and inventory transparency.
Another key driver of disruption is delayed or inconsistent payment to contracted suppliers. Delays in processing payments may disrupt the supply chain, particularly for small or emerging pharmaceutical vendors who operate within tighter financial margins. This issue was also explored in the previous article, Pricing Pressures and Affordability Challenges: Balancing Access and Sustainability in South Africa’s Medicine Market, where supplier payment delays were noted as a contributing factor to pricing and access concerns. Strengthening financial governance and streamlining payment mechanisms could contribute to more predictable supply timelines and supplier confidence.
Logistics infrastructure presents additional challenges. Many provincial depots lack modern inventory tracking systems, leading to delays in distribution, data inaccuracies, and reactive stock management. In rural areas, transport constraints and poor road infrastructure further complicate last-mile delivery, especially for temperature-sensitive medications like vaccines or insulin.
At the facility level, undertrained pharmacy personnel and a lack of digital inventory systems can make it difficult to manage stock levels proactively. Manual processes and paper-based stock cards are still common in many clinics, limiting the ability to predict shortages or make timely redistribution decisions within districts or provinces.
Interruptions in medicine supply can affect more than just stock levels—they can disrupt continuity of care, delay treatment initiation, and increase health system costs through avoidable complications. For patients managing chronic illnesses, even temporary stockouts may lead to treatment lapses, which can reduce therapeutic efficacy or result in additional clinical burden. In some cases, patients may be referred to private pharmacies to access their medication, introducing affordability challenges for those without medical coverage.
Several interventions have been introduced to address these challenges. The Department of Health has rolled out systems like RxSolution and SVS (Stock Visibility System) to digitize inventory management and improve visibility. These platforms allow for real-time monitoring of stock levels and enable quicker responses to pending shortages. However, adoption has been inconsistent, and technical support remains limited in some provinces.
Collaborations with the private sector—such as logistics providers, courier networks, and pharmaceutical distributors—are being explored to supplement existing capacity and introduce greater operational agility. Shared stock redistribution mechanisms and pooled procurement at district or regional levels may also assist in reducing stock variation between facilities.
Looking ahead, efforts to strengthen the medicine supply chain in South Africa will benefit from a combination of digital infrastructure expansion, enhanced supplier engagement, ongoing skills development, and robust data systems. A more agile, coordinated, and transparent approach to procurement and distribution can contribute significantly to ensuring uninterrupted access to essential medicines across all levels of care.
Medicine availability forms the final step in the access chain. Addressing supply chain challenges is therefore not only a matter of operational efficiency but a key determinant of health system reliability, service quality, and patient outcomes.